Cargando…

Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis

BACKGROUND: Interstitial lung disease (ILD) is the leading cause of mortality in patients with systemic sclerosis (SSc). Although the pathogenesis of SSc-ILD is not well understood, neutrophils may play a pivotal role in this process. Neutrophils store azurophil granules that contain defensins, anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakamoto, Noriho, Kakugawa, Tomoyuki, Hara, Atsuko, Nakashima, Shota, Yura, Hirokazu, Harada, Tatsuhiko, Ishimoto, Hiroshi, Yatera, Kazuhiro, Kuwatsuka, Yutaka, Hara, Toshihide, Ichinose, Kunihiro, Obase, Yasushi, Ishimatsu, Yuji, Kohno, Shigeru, Mukae, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676113/
https://www.ncbi.nlm.nih.gov/pubmed/26654954
http://dx.doi.org/10.1186/s12931-015-0308-1
_version_ 1782405113789284352
author Sakamoto, Noriho
Kakugawa, Tomoyuki
Hara, Atsuko
Nakashima, Shota
Yura, Hirokazu
Harada, Tatsuhiko
Ishimoto, Hiroshi
Yatera, Kazuhiro
Kuwatsuka, Yutaka
Hara, Toshihide
Ichinose, Kunihiro
Obase, Yasushi
Ishimatsu, Yuji
Kohno, Shigeru
Mukae, Hiroshi
author_facet Sakamoto, Noriho
Kakugawa, Tomoyuki
Hara, Atsuko
Nakashima, Shota
Yura, Hirokazu
Harada, Tatsuhiko
Ishimoto, Hiroshi
Yatera, Kazuhiro
Kuwatsuka, Yutaka
Hara, Toshihide
Ichinose, Kunihiro
Obase, Yasushi
Ishimatsu, Yuji
Kohno, Shigeru
Mukae, Hiroshi
author_sort Sakamoto, Noriho
collection PubMed
description BACKGROUND: Interstitial lung disease (ILD) is the leading cause of mortality in patients with systemic sclerosis (SSc). Although the pathogenesis of SSc-ILD is not well understood, neutrophils may play a pivotal role in this process. Neutrophils store azurophil granules that contain defensins, antimicrobial peptides that function in regulating the inflammatory response, and IL-8, a potent chemoattractant for neutrophils. The present study evaluated the levels of defensins and IL-8 in patients with SSc-ILD to determine their roles in disease pathogenesis. METHODS: Defensins (also known as human neutrophil peptides, HNPs) and IL-8 levels were measured in the serum and bronchoalveolar lavage fluid (BALF) of 33 patients with SSc-ILD and in 20 healthy controls by using ELISA. RESULTS: BALF analysis revealed a significant increase in HNPs in SSc-ILD patients (median; 240.0 pg/mL) than that of healthy controls (79.7 pg/mL). Additionally, IL-8 levels were higher in SSc-ILD patient serum and BALF as compared to healthy controls (16.4 pg/mL vs. 5.8 pg/mL and 15.4 pg/mL vs. 14.5 pg/mL, respectively). However, plasma HNPs levels were relatively unchanged. HNP and IL-8 levels in patient BALF displayed a significant positive correlation significantly correlated (r = 0.774, p <0.01), and which also correlated with clinical disease parameters—such as ILD biomarkers, pulmonary function tests, ratio of neutrophils and eosinophils in BALF, tricuspid regurgitation peak gradient (TRPG), and the extent of high-resolution computed tomography (HRCT) findings in the lung. Levels of plasma HNPs and serum IL-8 did not show a significant correlation with any clinical parameter. SSc-ILD progression was evaluated by pulmonary function tests, but no association was observed between VC change ratios and HNPs or IL-8 levels. CONCLUSIONS: BALF levels of HNPs and IL-8 were higher in SSc-ILD than in healthy controls, and are associated with various clinical disease parameters. Further studies are needed to clarify the role of defensins and IL-8 in SSc-ILD pathogenesis.
format Online
Article
Text
id pubmed-4676113
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46761132015-12-12 Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis Sakamoto, Noriho Kakugawa, Tomoyuki Hara, Atsuko Nakashima, Shota Yura, Hirokazu Harada, Tatsuhiko Ishimoto, Hiroshi Yatera, Kazuhiro Kuwatsuka, Yutaka Hara, Toshihide Ichinose, Kunihiro Obase, Yasushi Ishimatsu, Yuji Kohno, Shigeru Mukae, Hiroshi Respir Res Research BACKGROUND: Interstitial lung disease (ILD) is the leading cause of mortality in patients with systemic sclerosis (SSc). Although the pathogenesis of SSc-ILD is not well understood, neutrophils may play a pivotal role in this process. Neutrophils store azurophil granules that contain defensins, antimicrobial peptides that function in regulating the inflammatory response, and IL-8, a potent chemoattractant for neutrophils. The present study evaluated the levels of defensins and IL-8 in patients with SSc-ILD to determine their roles in disease pathogenesis. METHODS: Defensins (also known as human neutrophil peptides, HNPs) and IL-8 levels were measured in the serum and bronchoalveolar lavage fluid (BALF) of 33 patients with SSc-ILD and in 20 healthy controls by using ELISA. RESULTS: BALF analysis revealed a significant increase in HNPs in SSc-ILD patients (median; 240.0 pg/mL) than that of healthy controls (79.7 pg/mL). Additionally, IL-8 levels were higher in SSc-ILD patient serum and BALF as compared to healthy controls (16.4 pg/mL vs. 5.8 pg/mL and 15.4 pg/mL vs. 14.5 pg/mL, respectively). However, plasma HNPs levels were relatively unchanged. HNP and IL-8 levels in patient BALF displayed a significant positive correlation significantly correlated (r = 0.774, p <0.01), and which also correlated with clinical disease parameters—such as ILD biomarkers, pulmonary function tests, ratio of neutrophils and eosinophils in BALF, tricuspid regurgitation peak gradient (TRPG), and the extent of high-resolution computed tomography (HRCT) findings in the lung. Levels of plasma HNPs and serum IL-8 did not show a significant correlation with any clinical parameter. SSc-ILD progression was evaluated by pulmonary function tests, but no association was observed between VC change ratios and HNPs or IL-8 levels. CONCLUSIONS: BALF levels of HNPs and IL-8 were higher in SSc-ILD than in healthy controls, and are associated with various clinical disease parameters. Further studies are needed to clarify the role of defensins and IL-8 in SSc-ILD pathogenesis. BioMed Central 2015-12-10 2015 /pmc/articles/PMC4676113/ /pubmed/26654954 http://dx.doi.org/10.1186/s12931-015-0308-1 Text en © Sakamoto et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Sakamoto, Noriho
Kakugawa, Tomoyuki
Hara, Atsuko
Nakashima, Shota
Yura, Hirokazu
Harada, Tatsuhiko
Ishimoto, Hiroshi
Yatera, Kazuhiro
Kuwatsuka, Yutaka
Hara, Toshihide
Ichinose, Kunihiro
Obase, Yasushi
Ishimatsu, Yuji
Kohno, Shigeru
Mukae, Hiroshi
Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis
title Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis
title_full Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis
title_fullStr Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis
title_full_unstemmed Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis
title_short Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis
title_sort association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676113/
https://www.ncbi.nlm.nih.gov/pubmed/26654954
http://dx.doi.org/10.1186/s12931-015-0308-1
work_keys_str_mv AT sakamotonoriho associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis
AT kakugawatomoyuki associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis
AT haraatsuko associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis
AT nakashimashota associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis
AT yurahirokazu associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis
AT haradatatsuhiko associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis
AT ishimotohiroshi associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis
AT yaterakazuhiro associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis
AT kuwatsukayutaka associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis
AT haratoshihide associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis
AT ichinosekunihiro associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis
AT obaseyasushi associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis
AT ishimatsuyuji associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis
AT kohnoshigeru associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis
AT mukaehiroshi associationofelevatedadefensinlevelswithinterstitialpneumoniainpatientswithsystemicsclerosis